Arcutis Biotherapeutics (ARQT) FCF Margin (2022 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly FCF Margin of 1.97% for Q1 2026, up 5051.0% year-over-year from 0.04% in Q1 2025, and down 90.24% quarter-over-quarter from 20.22% in Q4 2025.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) FCF Margin (2022 - 2026) Analysis & Trends
Arcutis Biotherapeutics' FCF Margin history runs 5 years deep, the most recent figure standing at 1.97% for Q1 2026.
- In Q1 2026, FCF Margin rose 5051.0% year-over-year to 1.97%; the TTM figure through Mar 2026 stood at 6.44% (up 5992.0% YoY), while the FY2025 annual figure was 1.68%, up 6575.0% from the prior year.
- FCF Margin for Q1 2026 stood at 1.97%, down from 20.22% in the prior quarter.
- The five-year high for FCF Margin was 20.22% in Q4 2025, with the low at 9338.07% in Q3 2022.
- The 5-year median for FCF Margin is 115.58% (2023), against an average of 1111.79%.
- The sharpest annual moves came in 2023 and 2025: FCF Margin soared 922248 bps in 2023, then soared 2130 bps in 2025.
- Arcutis Biotherapeutics' FCF Margin stood at 2404.19% in 2022, then soared by 95 bps to 128.0% in 2023, then surged by 99 bps to 1.08% in 2024, then jumped by 1975 bps to 20.22% in 2025, then sank by 90 bps to 1.97% in 2026.
- Business Quant data shows ARQT's FCF Margin at 1.97% in Q1 2026, 20.22% in Q4 2025, and 1.77% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Arcutis Biotherapeutics | 3.12 Bn | 2.88 Bn | 118.92 Mn | 9.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.73% |
| Mar 31, 2026 | 1.97% |
| Dec 31, 2025 | 20.22% |
| Sep 30, 2025 | -1.77% |
| Jun 30, 2025 | 0.30% |
| Mar 31, 2025 | -47.06% |
| Dec 31, 2024 | -1.05% |
| Sep 30, 2024 | -77.83% |
| Jun 30, 2024 | -146.21% |
| Mar 31, 2024 | -63.76% |
| Dec 31, 2023 | -415.87% |
| Sep 30, 2023 | -115.58% |
| Jun 30, 2023 | -1,286.34% |
| Mar 31, 2023 | -2,891.98% |
| Dec 31, 2022 | -2,404.19% |
| Sep 30, 2022 | -9,338.07% |